Related by context. Frequent words. (Click for all words.) 64 pharmacokinetic studies 58 Phase IIa clinical trials 58 SILENOR TM 58 Complete Response 58 placebo controlled trials 57 carcinogenicity 56 axitinib 56 Phase 2b study 56 placebo controlled studies 56 European Medicines Evaluation 55 Marketing Authorization Application 55 BLA submission 55 Phase IIa trial 55 genotoxicity 55 acute toxicity 55 randomized controlled clinical trials 55 phase IIa 55 Approvable Letter 54 alvimopan 54 MAP# 54 pharmacokinetic 54 approvability 54 Phase 1b clinical 54 QT prolongation 54 preclinical studies 54 registrational 53 eltrombopag 53 vitro studies 53 Ampligen R 53 active comparator 53 preclinical 53 Complete Response letter 53 Phase 1b trial 53 subcutaneous injections 53 phase 2a 53 clinical endpoints 53 Pharmacokinetic 53 NDA submission 53 Investigational Device Exemption 53 alogliptin 53 elagolix 53 oritavancin 53 clinical trials 53 AZX# 53 randomized clinical trials 52 tolerability profile 52 bifeprunox 52 sBLA 52 Biologics License Application 52 genotoxic 52 administered subcutaneously 52 Immunogenicity 52 Phase 2a clinical 52 Phase III clinical trials 52 PROMACTA 52 Genasense R oblimersen 52 nab paclitaxel 52 PRX # 52 placebo controlled clinical 52 BYDUREON 52 Phase 2b trial 52 rHuPH# 51 Phase 2a trial 51 APF# 51 SCH # 51 secondary efficacy endpoints 51 NOXAFIL 51 teriparatide 51 Phase 2a 51 Phase IIb trial 51 iloperidone 51 NGX# 51 PROPEL trial 51 TRIOLEX 51 rNAPc2 51 Zenvia 51 Vilazodone 51 confirmatory Phase III 51 vivo efficacy 51 Homspera 51 anticancer agent 51 IDX# 51 glatiramer acetate 51 Phenoptin 51 efficacy endpoints 51 subgroup analyzes 51 prGCD 51 PREOS 51 New Drug Application 51 efficacy 51 hypercalcemia 51 Phase Ib 51 Complete Response Letter 51 Marketing Authorization Application MAA 51 Phase 1a 51 teduglutide 51 Ampligen 51 hepatotoxicity 50 Phase 2b 50 nitazoxanide 50 Phase III trials